Review of Screening Methods for Chronic Obstructive Pulmonary Disease in Primary Care

doi:10.12114/j.issn.1007-9572.2019.00.752

Abstract

Abstract: Chronic obstructive pulmonary disease（COPD） has become one of the diseases seriously affecting public health.The latest study showed that the prevalence of COPD amongst 40 years or older people was 13.7% in China，and estimated that there were 99 million COPD patients in China.However，how to identify such huge population and manage them is a big challenge in China now.Meanwhile，regarding of which screening methods are suitable for primary care has been one of the top questions for research globally in recent years.Currently，screening tools which have been studied more often include screening questionnaires，devices to test peak expiratory flow and microspirometers，and so on.There are also various screening modes，either using the tool alone or in combination.As primary care institutions are important places to manage COPD，this article summarizes the methods of COPD screening in primary care around the world，and discusses the problems and challenges of COPD screening in China's primary care，aiming at providing references for further studying of COPD screening methods suitable for primary care settings in China.

Key words: Pulmonary disease, chronic obstructive；Screening methods；Questionnaire；Expiratory peak flow meters；Microspirometers；Primary care；Current status

摘要： 慢性阻塞性肺疾病（简称慢阻肺）已经成为严重影响公共卫生的疾病之一。最新研究显示，中国40岁以上人群中慢阻肺患病率为13.7%，估测中国有9 900万慢阻肺患者，而如何发现该庞大的患病人群并实施管理是中国面临的巨大挑战，与此同时，采取何种方式进行慢阻肺筛查也已成为近年来国内外的研究热点。目前研究较多的筛查工具有筛查问卷、呼气峰流速仪以及微型肺量计，筛查方式也多种多样，有单独使用某种筛查工具的，也有多种筛查工具联合使用的。基层医疗机构是慢阻肺管理的重要场所，本文对国内外基层医疗机构的慢阻肺筛查方法进行综述，探讨中国基层慢阻肺筛查研究中存在的问题以及面临的挑战，旨在为未来开展适宜中国基层医疗机构的慢阻肺筛查研究提供参考。

关键词: 肺疾病, 慢性阻塞性；筛查方法；筛查问卷；呼气峰流速仪；微型肺量计；基层医疗；研究现状

PAN Zihan,CHI Chunhua,ZHENG Jiaqiang. Review of Screening Methods for Chronic Obstructive Pulmonary Disease in Primary Care　[J]. Chinese General Practice, 2020, 23(3): 257-266. DOI: 10.12114/j.issn.1007-9572.2019.00.752.
潘子涵,迟春花,郑家强. 基层医疗机构慢性阻塞性肺疾病筛查方法研究现状[J]. 中国全科医学, 2020, 23(3): 257-266. DOI: 10.12114/j.issn.1007-9572.2019.00.752.

References

［1］World Health Statistics 2017-Monitoring health for the SDGs
［EB/OL］．［2019-05-05］．http：//www.indiaenvironmentportal.org.in/content/442747/world-health-statistics-2017-monitoring-health-for-the-sdgs/.
［2］YIN P，WANG H，VOS T，et al．A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013：findings from the global burden of disease study 2013［J］．Chest，2016，150（6）：1269-1280．DOI：10.1016/j.chest.2016.08.1474.
［3］冯玉麟，王岚.中国COPD防治的难题［J］．中国呼吸与危重监护杂志，2012，11（4）：313-316．DOI：10.3969/j.issn.1671-6205.2012.04.001.
［4］ZHONG N S，WANG C，YAO W Z，et al．Prevalence of chronic obstructive pulmonary disease in China：a large，population-based survey［J］．Am J Respir Crit Care Med，2007，176（8）：753-760．DOI：10.1164/rccm.200612-1749OC.
［5］WANG C，XU J Y，YANG L，et al．Prevalence and risk factors of chronic obstructive pulmonary disease in China（the China Pulmonary Health［CPH］study）：a national cross-sectional study［J］．Lancet，2018，391（10131）：1706-1717．DOI：10.1016/S0140-6736（18）30841-9.
［6］国家卫生计生委办公厅关于印发中国居民慢性病与营养监测工作方案（试行）的通知［EB/OL］．（2018-11-26）［2019-05-01］．http：//www.nhfpc.gov.cn/jkj/s.
［7］关于印发《中国慢性病防治工作规划（2012—2015年）》的通知［EB/OL］．（2012-05-08）［2019-05-02］．http：//www.nhfpc.gov.cn/jkj/s.
［8］关于印发慢性阻塞性肺疾病分级诊疗服务技术方案的通知
［EB/OL］．（2017-02-27）［2019-05-03］．http：//www.nhfpc.gov.cn/jkj/s.
［9］国务院办公厅.中国防治慢性病中长期规划（2017—2025年）［EB/OL］．（2016-12-27）［2019-05-02］．http：//www.gov.cn/zhengce/content/2017-02/14/content_5167886.htm.
［10］国务院.“十三五”卫生与健康规划［EB/OL］．（2016-12-27）［2019-05-03］．http：//www.gov.cn/zhengce/content/2017-01/10/content_5158488.htm.
［11］褚国坤，朱惠莉.FEV1/FEV6、FEV3/FVC用于筛检慢性阻塞性肺疾病的意义［J］．国际呼吸杂志，2018，38（5）：370-373．DOI：10.3760/cma.j.issn.1673-436X.2018.05.011.
CHU G K，ZHU H L.Significance of FEV1/FEV6，FEV3/FVC for screening chronic obstructive pulmonary disease［J］．International Journal of Respiration，2018，38（5）：370-373．DOI：10.3760/cma.j.issn.1673-436X.2018.05.011.
［12］王小燕，夏国光，戴丽，等．使用便携式肺功能仪对烟草暴露人群筛查COPD的应用价值［J］．国际呼吸杂志，2018，38（18）：1381-1385．DOI：10.3760/cma.j.issn.1673-436X.2018.18.005.
WANG X Y，XIA G G，DAI L，et al．The role of portable spirometer on pulmonary function sceening of cigarettes exposed people［J］．International Journal of Respiration，2018，38（18）：1381-1385．DOI：10.3760/cma.j.issn.1673-436X.2018.18.005.
［13］VANDEVOORDE J，VERBANCK S，SCHUERMANS D，et al．FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction［J］．Chest，2005，127（5）：1560-1564．DOI：10.1378/chest.127.5.1560.
［14］REPRESAS-REPRESAS C，FERNáNDEZ-VILLAR A，RUANO-RAVI?A A，et al．Screening for chronic obstructive pulmonary disease：validity and reliability of a portable device in non-specialized healthcare settings［J］．PLoS One，2016，11（1）：e0145571．DOI：10.1371/journal.pone.0145571.
［15］KJELDGAARD P，LYKKEGAARD J，SPILLEMOSE H，et al．Multicenter study of the COPD-6 screening device：feasible for early detection of chronic obstructive pulmonary disease in primary care?［J］．Int J Chron Obstruct Pulmon Dis，2017，12：2323-2331．DOI：10.2147/COPD.S136244.
［16］VAN DEN BEMT L，WOUTERS B C，GROOTENS J，et al．Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care：a randomised cross-sectional study［J］．NPJ Prim Care Respir Med，2014，24：14033．DOI：10.1038/npjpcrm.2014.33.
［17］KIM J K，LEE C M，PARK J Y，et al．Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry［J］．Medicine（Baltimore），2016，95（50）：e5683．DOI：10.1097/MD.0000000000005683.
［18］冉丕鑫.应重视慢阻肺社区筛查适宜技术的研究与推广［J］．中华结核和呼吸杂志，2015，38（2）：87-88．DOI：10.3760/cma.j.issn.1001-0939.2015.02.004.
［19］中华医学会呼吸病学分会肺功能专业组.肺功能检查指南——呼气峰值流量及其变异率检查［J］．中华结核和呼吸杂志，2017，40（6）：426-430．DOI：10.3760/cma.j.issn.1001-0939.2017.06.006.
［20］THORAT Y T，SALVI S S，KODGULE R R.Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice：a cross-sectional study［J］．NPJ Prim Care Respir Med，2017，27（1）：32．DOI：10.1038/s41533-017-0036-8.
［21］JITHOO A，ENRIGHT P L，BURNEY P，et al．Case-finding options for COPD：results from the Burden of Obstructive Lung Disease study［J］．Eur Respir J，2013，41（3）：548-555．DOI：10.1183/09031936.00132011.
［22］JACKSON H，HUBBARD R.Detecting chronic obstructive pulmonary disease using peak flow rate：cross sectional survey［J］．BMJ，2003，327（7416）：653-654．DOI：10.1136/bmj.327.7416.653.
［23］刘亚男，许文兵，孟淑珍，等．探究峰流速仪呼气峰流速检测对慢性阻塞性肺疾病的筛查效力［J］．中国呼吸与危重监护杂志，2015，14（3）：250-254．DOI：10.7507/1671-6205.2015062.
LIU Y N，XU W B，MENG S Z，et al．The effectiveness of peak flow meter in COPD screening［J］．Chinese Journal of Respiratory and Critical Care Medicine，2015，14（3）：250-254．DOI：10.7507/1671-6205.2015062.
［24］TIAN J，ZHOU Y，CUI J，et al．Peak expiratory flow as a screening tool to detect airflow obstruction in a primary health care setting［J］．Int J Tuberc Lung Dis，2012，16（5）：674-680．DOI：10.5588/ijtld.11.0429.
［25］PRICE D B，TINKELMAN D G，HALBERT R J，et al．Symptom-based questionnaire for identifying COPD in smokers［J］．Respiration，2006，73（3）：285-295．DOI：10.1159/000090142.
［26］PRICE D B，TINKELMAN D G，NORDYKE R J，et al．Scoring system and clinical application of COPD diagnostic questionnaires［J］．Chest，2006，129（6）：1531-1539．DOI：10.1378/chest.129.6.1531.
［27］HALBERT R J，ISONAKA S.International Primary Care Respiratory Group（IPCRG） Guidelines：integrating diagnostic guidelines for managing chronic respiratory diseases in primary care［J］．Prim Care Respir J，2006，15（1）：13-19．DOI：10.1016/j.pcrj.2005.12.001.
［28］LEVY M L，FLETCHER M，PRICE D B，et al．International Primary Care Respiratory Group（IPCRG） Guidelines：diagnosis of respiratory diseases in primary care［J］．Prim Care Respir J，2006，15（1）：20-34．DOI：10.1016/j.pcrj.2005.10.004.
［29］KOTZ D，NELEMANS P，VAN SCHAYCK C P，et al．External validation of a COPD diagnostic questionnaire［J］．Eur Respir J，2008，31（2）：298-303．DOI：10.1183/09031936.00074307.
［30］STANLEY A J，HASAN I，CROCKETT A J，et al．Validation of the COPD Diagnostic Questionnaire in an Australian general practice cohort：a cross-sectional study［J］．Prim Care Respir J，2014，23（1）：92-97．DOI：10.4104/pcrj.2014.00015.
［31］王娟，许文兵，曾学军，等．中文版慢性阻塞性肺疾病筛查问卷在吸烟者中的初步检验与评价［J］．中华内科杂志，2012，51（4）：311-312．DOI：10.3760/cma.j.issn.0578-1426.2012.04.016.
［32］王石林，陈树丹，卢健聪，等．基于症状的COPD筛查问卷对COPD高危人员的相关性研究［J］．中外医疗，2014，33（13）：155-156．DOI：10.16662/j.cnki.1674-0742.2014.13.034.
［33］刘妍，邓笑伟.筛查问卷与肺功能检查在慢性阻塞性肺疾病早期诊断中的研究［J］．临床肺科杂志，2015，20（3）：500-503．DOI：10.3969/j.issn.1009-6663.2015.03.038.
LIU Y，DENG X W.Study of screening questionnaire and pulmonary function test in the early diagnosis of COPD［J］．Journal of Clinical Pulmonary Medicine，2015，20（3）：500-503．DOI：10.3969/j.issn.1009-6663.2015.03.038.
［34］KAWAYAMA T，MINAKATA Y，MATSUNAGA K，et al．Validation of symptom-based COPD questionnaires in Japanese subjects［J］．Respirology，2008，13（3）：420-426．DOI：10.1111/j.1440-1843.2008.01241.x.
［35］ZHANG Q，WANG M，LI X N，et al．Do symptom-based questions help screen COPD among Chinese populations?［J］．Sci Rep，2016，6：30419．DOI：10.1038/srep30419.
［36］MARTINEZ F J，RACZEK A E，SEIFER F D，et al．Development and initial validation of a self-scored COPD Population Screener Questionnaire（COPD-PS）［J］．COPD，2008，5（2）：85-95．DOI：10.1080/15412550801940721.
［37］TSUKUYA G，MATSUMOTO K，FUKUYAMA S，et al．Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population：the HISAYAMA study［J］．Allergol Int，2015，64（1）：49-53．DOI：10.1016/j.alit.2014.06.002.
［38］中华医学会，中华医学会杂志社，中华医学会全科医学分会，等．慢性阻塞性肺疾病基层诊疗指南（实践版?2018）［J］．中华全科医师杂志，2018，17（11）：871-877．DOI：10.3760/cma.j.issn.1671-7368.2018.11.003.
［39］YAWN B P，MAPEL D W，MANNINO D M，et al．Development of the Lung Function Questionnaire（LFQ） to identify airflow obstruction［J］．Int J Chron Obstruct Pulmon Dis，2010，5：1-10.
［40］HANANIA N A，MANNINO D M，YAWN B P，et al．Predicting risk of airflow obstruction in primary care：Validation of the lung function questionnaire（LFQ）［J］．Respir Med，2010，104（8）：1160-1170．DOI：10.1016/j.rmed.2010.02.009.
［41］DALAL A A，DEMURO-MERCON C，LEWIS S，et al．Validation of alternate modes of administration of the lung function questionnaire（LFQ） in subjects with smoking history［J］．Int J Chron Obstruct Pulmon Dis，2010，5：425-434．DOI：10.2147/COPD.S13900.
［42］ZHOU Y M，CHEN S Y，TIAN J，et al．Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China［J］．Int J Tuberc Lung Dis，2013，17（12）：1645-1651．DOI：10.5588/ijtld.12.0995.
［43］MARTINEZ F J，MANNINO D，LEIDY N K，et al．A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease［J］．Am J Respir Crit Care Med，2017，195（6）：748-756．DOI：10.1164/rccm.201603-0622OC.
［44］SPYRATOS D，HAIDICH A B，CHLOROS D，et al．Comparison of three screening questionnaires for chronic obstructive pulmonary disease in the primary care［J］．Respiration，2017，93（2）：83-89．DOI：10.1159/000453586.
［45］SOGBETUN F，ESCHENBACHER W L，WELGE J A，et al．A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease［J］．Respir Med，2016，120：1-9．DOI：10.1016/j.rmed.2016.09.010.
［46］TSUKUYA G，SAMUKAWA T，MATSUMOTO K，et al．Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population：the Hisayama study［J］．Int J Chron Obstruct Pulmon Dis，2016，11：1903-1909．DOI：10.2147/COPD.S110429.
［47］HAROON S，JORDAN R，TAKWOINGI Y，et al．Diagnostic accuracy of screening tests for COPD：a systematic review and meta-analysis［J］．BMJ Open，2015，5（10）：e008133．DOI：10.1136/bmjopen-2015-008133.
［48］SICHLETIDIS L，SPYRATOS D，PAPAIOANNOU M，et al．A combination of the IPAG questionnaire and PiKo-6? flow meter is a valuable screening tool for COPD in the primary care setting［J］．Prim Care Respir J，2011，20（2）：184-189，1 p following 189．DOI：10.4104/pcrj.2011.00038.
［49］FRITH P，CROCKETT A，BEILBY J，et al．Simplified COPD screening：validation of the PiKo-6? in primary care［J］．Prim Care Respir J，2011，20（2）：190-198，2 p following 198．DOI：10.4104/pcrj.2011.00040.
［50］MING L，NEOH C F，SUI C F，et al．VitalQPlus：a potential screening tool for early diagnosis of COPD［J］．Int J Chronic Obstr Pulm Dis，2015：1613．DOI：10.2147/copd.s84618．
［51］SORIANO J B，MOLINA J，MIRAVITLLES M.Combining case-finding methods for COPD in primary care：a large，two-stage design study［J］．Int J Tuberc Lung Dis，2018，22（1）：106-111．DOI：10.5588/ijtld.17.0334.
［52］陈亚红.2018年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读［J］．中国医学前沿杂志：电子版，2017，9（12）：15-22．DOI：10.12037/YXQY.2017.12-05.
CHEN Y H.Interpretation of global initiative for chronic obstructive lung disease global strategy for the diagnosis，management，and prevention of chronic obstructive pulmonary disease 2018 report［J］．Chinese Journal of the Frontiers of Medical Science：Electronic Version，2017，9（12）：15-22．DOI：10.12037/YXQY.2017.12-05.
［53］HAROON S，ADAB P，RILEY R D，et al．Predicting risk of undiagnosed COPD：development and validation of the Target COPD score［J］．Eur Respir J，2017，49（6）：1602191．DOI：10.1183/13993003.02191-2016.
［54］冯倩，余勤.6分钟步行试验在慢性肺病中应用的研究进展［J］．临床荟萃，2013，28（1）：115-118．DOI：10.3969/j.issn.1004-583X.2013.01.053.
［55］禹海燕，凌勇.6min步行试验对慢性阻塞性肺疾病患者病情分级及生活质量的影响［J］．中国药物经济学，2014，9（4）：86-87.
［56］崔冬清，王虹.六分钟步行试验评判慢性阻塞性肺疾病肺功能影响因素分析［J］．中国全科医学，2010，13（16）：1768-1770．DOI：10.3969/j.issn.1007-9572.2010.16.020.
CUI D Q，WANG H.Influencing factors to six minute walk test for assessing pulmonary function of chronic obstructive pulmonary disease［J］．Chinese General Practice，2010，13（16）：1768-1770．DOI：10.3969/j.issn.1007-9572.2010.16.020.
［57］沈楚婕，张伟.慢性阻塞性肺疾病早期筛查方法及临床意义［J］．国际呼吸杂志，2015，35（15）：1144-1148．DOI：10.3760/cma.j.issn.1673-436X.2015.15.007.
SHEN C J，ZHANG W.Feasible methods and the clinical meaning of early detection for chronic obstructive pulmonary disease［J］．International Journal of Respiration，2015，35（15）：1144-1148．DOI：10.3760/cma.j.issn.1673-436X.2015.15.007.
［58］CHAN K Y，LI X，CHEN W J，et al．Prevalence of chronic obstructive pulmonary disease（COPD） in China in 1990 and 2010［J］．J Glob Health，2017，7（2）：020704．DOI：10.7189/jogh.07.020704.

[1]	LIU Jian, ZHANG Tianyi, AILIZHATI ·Aizezi, CHANG Ruijing, ZHANG Jianli, WANG Wan, JIANG Peng. Cardiopulmonary Physiology Effects of Wearing a Surgical Mask Versus an N95 Respirator in Patients with COPD during Walking: a Randomized Crossover Controlled Trial [J]. Chinese General Practice, 2023, 26(24): 3028-3032.
[2]	SHEN Junxi, ZHU Xing, CHEN Yunzhi, LI Wen. Novel Developments in Lung and Gut Microbiota and Their Cross-talk with the Development of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(20): 2548-2554.
[3]	LIANG Zhenyu, WANG Fengyan, CHEN Zizheng, CHEN Rongchang. Updated Key Points Interpretation of Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report) [J]. Chinese General Practice, 2023, 26(11): 1287-1298.
[4]	WANG Tong, QUAN Haishan, TIAN Bowen, LI Ying, CUI Qianqian, LIU Yao, ZHU Huahua. Fatigue in Chronic Obstructive Pulmonary Disease: a Scoping Review [J]. Chinese General Practice, 2023, 26(07): 893-902.
[5]	LIU Jiancai, ZHENG Hanyin, PAN Hui, YE Linglan, LI Chuanfen. Perceptions of Chronic Obstructive Pulmonary Disease among Chronic Disease Managers in Primary Care in Rural Areas [J]. Chinese General Practice, 2023, 26(07): 877-885.
[6]	WANG Yide, LI Zheng, LI Fengsen. Role of Endocrine Function of Adipose Tissue in the Development of Chronic Obstructive Pulmonary Disease: a Review of Recent Advances [J]. Chinese General Practice, 2023, 26(06): 754-759.
[7]	HU Yiqing, FANG Jiwei, LIU Huanbing. Attaching Importance to the Application of Lung Function Examination Technology in Grassroots Medical and Health Institutions——Expert Answers to Key Questions [J]. Chinese General Practice, 2023, 26(05): 532-540.
[8]	SHI Weijuan, WANG Fengyan, YANG Yuqiong, XIE Qingxiu, LI Yuqi, LI Shiyue, CHEN Rongchang, ZHANG Dongying, ZHENG Jinping, LIANG Zhenyu. Impact of COVID-19 Pandemic on the Frequency of Acute Exacerbations of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(05): 550-556.
[9]	BAI Yahu, GAO Shenghan, JI Siyu, SHANG Jinyu, DONG Yanchun, NING Kang. Pre-COPD: a New Advance in COPD [J]. Chinese General Practice, 2023, 26(03): 268-273.
[10]	GUO Dongwei, ZHANG Pengfei, REN Mingjun, LIAO Lijun, HUANG Ruyan, LUO Xiangrong. Mechanistic of Ginkgo Biloba Extract in the Prevention and Treatment of COPD: Regulating Autophagy in Alveolar Macrophages via PI3K/Akt/mTOR Signaling Pathways [J]. Chinese General Practice, 2023, 26(03): 293-303.
[11]	HUANG Tao, LUO Na, LUO Song, XU Qin. Clinical Application of a Novel Noninvasive Positive Pressure Ventilation Face Mask with Two Channels and Constant Leakage for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Carbon Dioxide Retention [J]. Chinese General Practice, 2023, 26(03): 343-347.
[12]	FANG Ziyan, LI Xueer, YANG Xuening, LIU Jing, YANG Congyan, ZHANG Feng, AKIMANA Sandra, WANG Yan, ZHANG Jing. Effect of Fatigue on the Possibility of Acute Exacerbation in COPD: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(03): 287-292.
[13]	WU Jiankang, CHEN Yan. Interpretation of the Lancet Commission on Towards the Elimination of Chronic Obstructive Pulmonary Disease: New Definition and Recommendations for Clinical Management of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(02): 127-133.
[14]	CHANG Chun, SUN Yongchang. Global Strategy for Asthma Management and Prevention: Interpretation of the Updates in 2022 [J]. Chinese General Practice, 2022, 25(35): 4355-4362.
[15]	LIU Yue, YUAN Yuan. Diagnostic Accuracy of Screening Tools for Chronic Obstructive Pulmonary Disease: a Network Meta-analysis [J]. Chinese General Practice, 2022, 25(35): 4443-4452.